P&G Hygiene Q4 FY26 profit falls 2%, revenue down 5% to ₹941 crore
Synopsis
Key Takeaways
Procter and Gamble Hygiene and Health Care Limited reported a 2 per cent decline in consolidated net profit for the fourth quarter of fiscal 2026 (Q4 FY26), even as operating margins improved sharply during the period. The Mumbai-headquartered FMCG firm posted a net profit of ₹153 crore for the January–March 2026 quarter, down from ₹156 crore in the same period a year earlier, according to its stock exchange filing.
Revenue and Margin Performance
Revenue from operations fell 5.1 per cent year-on-year to ₹941 crore in Q4 FY26, compared with ₹992 crore in Q4 FY25. Despite the top-line pressure, the company's operating performance held up. EBITDA rose 4.1 per cent to ₹218 crore from ₹210 crore in the year-ago quarter, while the EBITDA margin expanded to 23.2 per cent from 21.1 per cent — a gain of over 200 basis points. The divergence between falling revenues and improving margins suggests the company leaned on cost efficiencies and product-mix optimisation to protect profitability.
Final Dividend Declared for FY26
P&G Hygiene announced a final dividend of ₹60 per equity share for fiscal 2026, with a total payout to shareholders expected to amount to approximately ₹194.76 crore. The record date for determining eligible shareholders has been fixed as 17 August. The dividend is subject to shareholder approval at the forthcoming annual general meeting and will be paid from 18 September onwards.
Full-Year Dividend Trail
The final dividend follows a series of payouts during the fiscal year. Earlier in February 2026, the company had declared an interim dividend of ₹170 per share along with a special dividend of ₹25 per share. In prior payouts, the company distributed ₹65 per share in August 2025, an interim dividend of ₹110 per share in February 2025, and ₹95 per share in November 2024. Cumulatively, these distributions reflect the company's continued commitment to shareholder returns even in a quarter marked by revenue softness.
What to Watch
The revenue decline in Q4 FY26 raises questions about near-term demand trends in the hygiene and health care segment, particularly as urban consumption faces uneven recovery. Analysts will likely scrutinise whether the margin expansion is structural or driven by one-off cost savings. The company's performance in the first quarter of FY27 will be a key indicator of whether revenue momentum can be restored.